Insmed short interest increased 100,000 shares the last 2 weeks \it is obvious why. The idiot village has the same few pushing a failed drug that no one has any interest in. STAY THERE!
terry_insm has a good sized position and it was he that made the 14.98 strong buy call but he is trading the stock.Kathy is parroting some of his comments on a paid trading venue.This comment from last week was a discussion that would never be allowed on the freebie MBs.Terry said it was ok to post "Reason INSM cant go it alone. Arikayce market penetration.Today I spoke with a endocrinologist about how a device he was using for his diabetes was working. Dr @#$%$#@#$%^ who is a Type1 who used to inject a couple of times a day -insulin. But today he uses a inhale-able insulin device about which he raves.He demonstrated the 10 sec application with ease. The device is made by Mannkind It is FDA approved so why are scripts (300ish) so low? This is where reality and stocks part ways .Why isnt Mannkinds device making "Billions" as was projected just a couple of years ago? Mannkinds inhaler is not the first.Pfizer had one a few years ago and it was a bust.This one is far better.The reality is in real life,market penetration by new drugs\devices is very slow. It is reality that physicians and even specialists in the field are slow to adapt to new technologies.It will take imo at least 2 years to see how really successful arikayce may be -that is if all goes well and I am writing this more of a market condition aspect vs a share holder. The timeline of PE scrips and application is always a lull in a stock action after hopefully a big run for shareholders like me- and we can find another biotech that has promise and market conditions and sentiment that enable a stock run up/
Insm is trading with the markets If Trumps health hence then tax initiatives fail the market will turn down There is no reason to value Insmed at more than a billion A few more months to go
April 25 2017= 2 months ago INSM was $ 19.23
Cubbie! very first post this AM on that board! lol! \ .If anyone possibly believes this they should not be posting #$%$.\"Would make sense then for Novartis to see the results" TAKE THIS TO THE BANK \ PH111 RESULTS ARE BLINDED AND NO ONE ******NO ONE*** HAS SEEN THE DATA.\they may have an impression but they DO NOT KNOW THE RESULTS
INVESTOR VILLAGE IDIOTS SAY "drug stocks taking a big jump today" "and as usual insm is taking another big dump in late trading " NOT ! Pharmas making money making big jump INSM is short covering . BIG CAPS are breaking out \small upstarts are starting to get back to a few months ago \
repeat post:To the dychd removing others posts How much have you lost on INSM? by fmrick \concise explanation to the idiots who dont know about markets. "Today the XBI is up big again. Some of mine are up and some are down. They each affect the XBI to the extent their percentage contributes to the ETF. But none trade in lock step with the XBI. Plus, the XBI's value is just the combination of all the stocks it owns. So when one stock goes up, that part of the XBI goes up. Down is the same. Any index is going to go up or down depending on what the underlining stocks do. It is an index of those stocks. It reflects the value of the stocks in it. No more or no less.
My guess is that INSM is due for a pullback in the short-run. I started receiving notifications from awe.some.stock_s the other week and so far they have presented interesting new trade ideas.
The stock is bought There is no manipulation The short interest build a position and have acted on it.
The idiot investor village board doesn't even realize \that Arikayce replacement and diagnosis will be the advances in the genetic testing diagnosis and development of new antibiotics\One is close one is a few years \away but both will be advances in respiratory treatment\ same 5 or 6 morons \ Trade on \
Stop whining The stock is very cheap or very expensive .If they fail the company will be pennies on the dollar.If they make it across the finish line it will be an acquisition target.INSMED is not all biotecks with no revenues slapped back 5 years
We keep getting the shaft! INSM GLBT club
S-8 \ Here is the offering! \ 84 million for management! \beyond ripoff\this insures Insmed can sell the company for a lower price\
Roller coaster As long as the trend remains up. I guess we will have to expect this all the way into results 3 or 4 months
INSM Citigroup Reiterates ! Price Target - $ 17.00 \ 4 analysts have issued 1-year price objectives for Insmed's shares\ they expect Insmed's share price to reach $22.67 in the next twelve months.
deleting posts especially from some experienced and then posting hype is why most INSM shareholders have made little moneyI admit I got burned bad years ago and listen to those that make constructive points.Maybe arikayce will fail.Arikayce failed Phase two no matter how great a "cure spin" you put on it.The FDA wants both endpoints to be met this time is my understanding or there will be more trials.6 Years after I first heard Insmed was launch ready next year it is not.
Perhaps a short-term pull back is more likely before the next rally on INSM? google awe_some_stocks - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
Anyone? verified Clinicaltrials . gov Study Start Date: October 2016 Estimated Study Completion Date: December 2019 Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)